SAN DIEGO, Feb. 15, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, today announced the presentation of initial data from an ongoing investigator sponsored Phase 1/2 clinical trial of sitravatinib in combination with nivolumab (OPDIVO®) in patients with advanced clear cell renal cell cancer (a

SAN DIEGO, Feb. 15, 2020 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Adverum Biotechnologies, Inc. ("Adverum " or the "Company" (NASDAQ: ADVM) on behalf of investors.  The investigation seeks to determine whether certain statements regarding the results of a clinical drug study of ADVM-022 were false and mi

WOODCLIFF LAKE, N.J., Feb. 15, 2020 /PRNewswire/ -- Eisai presented today results from a Phase 2 trial assessing the efficacy and safety of lenvatinib (marketed as LENVIMA®) in combination with everolimus (LEN+EVE) in patients with unresectable advanced or metastatic non-clear cell renal cell carcinoma (nccRCC) (Abstract #685) at the 2020 Genitourinary Can

SUZHOU, China, Feb. 15, 2020 /PRNewswire/ -- A mathematical model set up by an ad-hoc group of scientists indicates the number of currently infected novel coronavirus cases in China are on the decline as of February 12.  Currently infected cases are those confirmed to be ill with the virus who have not yet recovered or died.

KUALA LUMPUR, Malaysia, Feb. 15, 2020 /PRNewswire/ -- Informa Markets, the leading exhibition organiser in Malaysia, is supporting the government's efforts to share factual and up-to-date information on the COVID-19 situation in Malaysia with the business community

ATLANTA, Feb. 14, 2020 /PRNewswire/ -- Aveanna Healthcare ("Aveanna") is providing notice of a recent incident that may impact certain patients and employees.  While Aveanna is unaware of any attempted or actual misuse of this information, notice is being provided to potentially affected individuals, as well as certain state and federal regulators. 

NASHVILLE, Tenn., Feb. 14, 2020 /PRNewswire/ -- Tennessee Orthopaedic Alliance ("TOA") has learned of a data security incident that involved protected health information belonging to certain current and former patients.  On February 14, 2020, TOA notified potentially impacted individuals and provided resources to assist them.

SILVER SPRING, Md., Feb. 14, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today approved three drugs for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The FDA approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1%) for the temporary relief of arthritis pain;  Pataday Twice Daily

NEW YORK, Feb. 14, 2020 /PRNewswire/ -- JDRF, the leading global organization funding type 1 diabetes (T1D) research, funded $121.5 million directly and helped generate more than

SILVER SPRING, Md., Feb. 14, 2020 /PRNewswire/ -- The FDA plays an essential role in overseeing our Nation's medical products as part of our vital mission to protect and promote public health, including during public health emergencies. The FDA is an active partner in the Novel Coronavirus (COVID-19) response, working closely with our government and public health pa